@inproceedings{inproceedings, title  = {{PATIENT REPORTED OUTCOME MEASURES IN THE FREEDM2 RANDOMISED CONTROLLED TRIAL: FREESTYLE LIBRE 3 IN T2DM ON BASAL INSULIN PLUS SGLT2 INHIBITOR AND/OR GLP-1 AGONIST}},

 url = {{}},

 year = {{2026}},

 month = {{3}},

 author = {{Leelarathna L and Moore P and Sathyapalan T and Choudhary P and Lim J and Neupane S and Iqbal A and Evans M and Rayman G and Price H and Ajjan R et al}},

 volume = {{28}},

 journal = {{DIABETES TECHNOLOGY & THERAPEUTICS}},

 pages = {{287S-288S}},

 note = {{Accessed on 2026/04/25}}}